Artículos por temáticas

Assessment of spasticity after stroke using clinical measures: a systematic review.

Aloraini SM, Gäverth J, Yeung E, MacKay-Lyons M.

Disabil Rehabil. 2015;37(25):2313-23. doi: 10.3109/09638288.2015.1014933. Review.

Body Sensor Network-Based Spasticity Detection.

Misgeld B, Luken M, Heitzmann D, Wolf S, Leonhardt S.

IEEE J Biomed Health Inform. 2015 Sep 8. [Epub ahead of print]

Chronic Spinal Cord Stimulation in the Treatment of Cerebral and Spinal Spasticity.

Dekopov AV, Shabalov VA, Tomsky AA, Hit MV, Salova EM.

Stereotact Funct Neurosurg. 2015 Feb 27;93(2):133-139. [Epub ahead of print]

Hematuria following Botox treatment for upper limb spasticity: a case report.

Lo TC, Yeung ST, Lee S, Chang EY.

J Pain Res. 2015 Sep 14;8:619-22. doi: 10.2147/JPR.S88658.

[A breakthrough for the treatment of spasticity in multiple sclerosis].

Lebrun C, Vermersch P.

Rev Neurol (Paris). 2015 Apr;171(4):327-8. doi: 10.1016/j.neurol.2015.03.002. French. No abstract available.

Muscle relaxants--the current position in the treatment of spasticity in orthopedics.

Zygmunt M, Sapa J.

Ortop Traumatol Rehabil. 2015 Jul-Aug;17(4):423-30. doi: 10.5604/15093492.1173500.

Erratum to: cost effectiveness of Oromucosal cannabis-based medicine (Sativex(®)) for spasticity in multiple sclerosis.

Lu L, Pearce H, Roome C, Shearer J, Lang IA, Stein K.

Pharmacoeconomics. 2015 Jun;33(6):611. doi: 10.1007/s40273-015-0262-2. No abstract available.

Understanding the reasons for delayed referral for intrathecal baclofen therapy in pediatric patients with severe spasticity.

Berman CM, Eppinger MA, Mazzola CA.

Childs Nerv Syst. 2015 Mar;31(3):405-13. doi: 10.1007/s00381-014-2591-4.

Systematic literature review of abobotulinumtoxinA in clinical trials for adult upper limb spasticity.

Dashtipour K, Chen JJ, Walker HW, Lee MY.

Am J Phys Med Rehabil. 2015 Mar;94(3):229-38. doi: 10.1097/PHM.0000000000000208. Review.

Placebo effects in a multiple sclerosis spasticity enriched clinical trial with the oromucosal cannabinoid spray (THC/CBD): dimension and possible causes.

Di Marzo V, Centonze D.

CNS Neurosci Ther. 2015 Mar;21(3):215-21. doi: 10.1111/cns.12358. Review.

Neuronox versus BOTOX in the Treatment of Post-Stroke Upper Limb Spasticity: A Multicenter Randomized Controlled Trial.

Seo HG, Paik NJ, Lee SU, Oh BM, Chun MH, Kwon BS, Bang MS.

PLoS One. 2015 Jun 1;10(6):e0128633. doi: 10.1371/journal.pone.0128633.

The relationship between isokinetic muscle strength and spasticity in the lower limbs of stroke patients.

Abdollahi I, Taghizadeh A, Shakeri H, Eivazi M, Jaberzadeh S.

J Bodyw Mov Ther. 2015 Apr;19(2):284-90. doi: 10.1016/j.jbmt.2014.07.002.

Correlation of knee proprioception with muscle strength and spasticity in stroke patients.

Yang JM, Kim SY.

J Phys Ther Sci. 2015 Sep;27(9):2705-8. doi: 10.1589/jpts.27.2705.

The need for and provision of intrathecal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistics database.

Narendran RC, Duarte RV, Valyi A, Eldabe S.

BMJ Open. 2015 Jun 30;5(6):e007517. doi: 10.1136/bmjopen-2014-007517.

Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis Spasticity in Italy: First Data from a Large Observational Study.

Trojano M, Vila C.

Eur Neurol. 2015;74(3-4):178-85. doi: 10.1159/000441619.